Kestra Medical (KMTS) Insider Grant: 10,909 RSUs to Director Jeffrey Schwartz
Rhea-AI Filing Summary
Jeffrey Lawrence Schwartz, a partner at Bain Capital Investors and a director/10% owner of Kestra Medical Technologies, acquired 10,909 restricted stock units (RSUs) on 09/04/2025. Each RSU converts to one common share and the RSUs vest on 09/04/2026 subject to continued service. After the reported acquisition Mr. Schwartz beneficially owns 10,909 shares directly and 27,019,225 shares indirectly, the latter held by Bain Charger Holdings, L.P. and West Affum Holdings, L.P., with Bain Capital entities holding controlling interests. Mr. Schwartz disclaims beneficial ownership except to the extent of his pecuniary interest.
Positive
- Director alignment: Time-vesting RSUs align the reporting persons incentives with long-term shareholder value.
- Full disclosure: The filing discloses indirect holdings and the ownership structure through Bain-affiliated entities.
Negative
- Concentration of control: A large block of 27,019,225 indirect shares is held by Bain-affiliated vehicles, indicating concentrated influence which may concern some investors.
Insights
TL;DR: Routine insider equity grant; signals alignment but minimal immediate market impact given large existing indirect holdings.
The reported grant of 10,909 RSUs is a standard long-term compensation vehicle tying executive incentives to equity performance. Vesting is time-based one year out, which supports retention. The incremental economic stake is small relative to the reported 27,019,225 indirect shares tied to Bain-affiliated vehicles, so the marginal effect on control or market float is negligible. For investors, this demonstrates continued alignment of the director with shareholder outcomes but does not represent a material change in ownership or control.
TL;DR: Governance-wise this is a customary director grant; disclosure clarifies indirect ownership through Bain entities.
The Form 4 properly discloses both the time-vesting RSUs and the web of indirect holdings through Bain Charger and West Affum, preserving transparency about potential shared voting/dispositive power. The filing includes the required disclaimer of beneficial ownership except for pecuniary interest, which is standard when ownership is held in affiliated partnerships. No unusual derivative or disposition activity is reported, indicating no immediate governance changes.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Shares | 10,909 | $0.00 | -- |
| holding | Common Shares | -- | -- | -- |
Footnotes (1)
- The reported securities represent restricted stock units ("RSUs") which each entitle the Reporting Person to receive one common share of the Issuer. The RSUs will vest on September 4, 2026, subject to the Reporting Person's continued service through such date. Represents 7,109,944 common shares of the Issuer held directly by Bain Charger Holdings, L.P. ("Bain Charger') and 19,909,281 common shares of the Issuer held directly by West Affum Holdings, L.P. ("West Affum"). Bain Charger is the sole shareholder of West Affum GP Ltd., which is the general partner of West Affum. Mr. Schwartz is a Partner of Bain Capital Investors, LLC, which is the general partner of Bain Charger. As a result, Mr. Schwartz may be deemed to share voting and dispositive power with respect to the securities held by Bain Charger and West Affum. Mr. Schwartz disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
